Using Data to Improve
Linkage to Care
Debbie Wendell, PhD, MPH
Louisiana STD/HIV Program
Louisiana STD/HIV Program
How can data be used to improve
programs?
• Where are the biggest gaps in the HIV
continuum of care?
• Are there race, gender or age disparities?
• How quickly are clients getting linked to
care?
• Are clients retained in care?
• How does my agency compare to others?
How do we measure linkage, retention and
viral suppression?
• Use CD4/VL results as a proxy for an
HIV-related medical visit
o All HIV-related test results are reportable in Louisiana
o Most are reported electronically on a daily basis
• Measurement standards
o Linkage: Was a person newly-diagnosed with HIV
linked to HIV-related medical care within 90 days?
o Retention: Did a person living with HIV have 2 or more
care visits within a 12 month period?
o Viral Suppression: Was the most recent VL <=200?
HIV Continuum of Care
Louisiana, 2013
100%
69%
54%
49%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Persons living with HIV In HIV care Retained in HIV care Viral suppression
(<=200)
Percentage
18,199
9,774
12,536
8,831
70% of PLWH in care were virally suppressed
Louisiana STD/HIV Program
Percent Retained in Care among PLWH
by Region, Louisiana, 2013
Louisiana STD/HIV Program
52%
60% 60%
54%
46%
51%
46%
51%
53%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Percentage
Region
Louisiana STD/HIV Program
Percent Virally Suppressed among PLWH in Care
by Region, Louisiana, 2013
Louisiana STD/HIV Program
68%
71%
75% 75%
71% 71% 68%
72%
76%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Percentage
Region
Louisiana STD/HIV Program
HIV Continuum of Care by Race/Ethnicity
Louisiana, 2013
100% 100% 100%
70%
45%
70%
54%
35%
55%
46%
35%
58%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Black Hispanic White
Percentage
PLWH
In HIV care
Retained in care
Viral suppression
66% of PLWH in
care were virally
suppressed
77% of PLWH in
care were virally
suppressed
82% of PLWH in
care were virally
suppressed
N = 12,442 N = 693 N = 4,861
Louisiana STD/HIV Program
HIV Testing by Site Type
Louisiana, 2013
Total Number of
Tests
(% of Tests)
Number of
Positive
Results
% Positivity
Total
Positives
Number of
New
Positives
% Positivity
New
Positives
Total 95,656 1,069 1.1% 532 0.6%
Parish health unit 36,347 (38%) 226 0.6% 146 0.4%
Emergency department 19,484 (20%) 235 1.2% 130 0.7%
Correctional facility 16,385 (17%) 275 1.7% 27 0.2%
Community-based org 15,701 (16%) 279 1.8% 198 1.3%
Community health clinic 4,206 (4%) 45 1.1% 25 0.6%
Substance abuse clinic 2,805(3%) 5 0.2% 2 0.7%
School/college 728 (1%) 4 0.5% 4 0.5%
Linkage to Care within 90 Days
Louisiana, 2007 -2014
67%
70% 70%
73% 74%
78% 79%
83%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2007 2008 2009 2010 2011 2012 2013 2014
Year of Diagnosis
National HIV/AIDS Strategy Objective: 85%
Louisiana STD/HIV Program
Linkage to Care within 90 Days
by Region, 2013
Louisiana STD/HIV Program
78%
74%
86%
78%
90%
87%
74%
83%
85%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Percentage
Region
National HIV/AIDS Strategy Objective: 85%
Louisiana STD/HIV Program
Linkage to Care – New Positives
By Site Type, Louisiana, 2013
Number of
New
Positive
Results
Number
Linked to
Care within
90 Days
% Linked to
Care within
90 Days
Total 532 365 69%
Community-based org 198 138 70%
Parish health unit 146 85 58%
Emergency department 130 111 85%
Correctional facility 27 12 44%
Community health clinic 25 17 69%
Substance abuse clinic 2 0 0%
School/college 4 2 50%
Time to Linkage to Care
New Positives - CBOs, Louisiana, 2013
0
10
20
30
40
50
0-7 8-15 16-30 31-45 46-90 91-180 181-270 >270
Days to Entry into Care
Louisiana STD/HIV Program
Linkage to Care within 90 Days
New Positives - CBOs, Louisiana, 2013
79%
100%
54%
81% 80%
57%
84%
70%
60%
100% 100%
0%
20%
40%
60%
80%
100%
A B C D E F G H I J K
CBO
Louisiana STD/HIV Program
National HIV/AIDS Strategy Objective: 85%
Linkage to Care – New Positives
By Gender and Race/Ethnicity, CBOs, 2013
Number of
New
Positive
Results
Number
Linked to
Care within
90 Days
% Linked to
Care within
90 Days
Total 198 138 70%
Female 30 16 53%
Male 168 122 73%
African American/Black 118 73 62%
Hispanic/Latino 6 6 100%
White 68 55 81%
Linkage to Care – New Positives
By Age Group, CBOs, 2013
Number of
New
Positive
Results
Number
Linked to
Care within
90 Days
% Linked to
Care within
90 Days
Total 198 138 70%
16-24 years old 65 48 74%
25-44 years old 99 68 69%
>=45 years old 33 21 64%
Initial CD4 and Viral Load
CBOs, 2013
• CD4 count
o Range: 6 - 1,169
o Median: 448
o Average: 439
o 28 clients had a CD4 count <=200 (meet AIDS case
definition)
• Viral load
o Range: <20 – 5,589,140
o Median: 37,080
o Average: 164,125
o 8 clients had a VL<=200 (i.e., virally suppressed)
HIV Continuum of Care - 2014
CBO – New Positives Diagnosed in 2013
100%
76%
60%
56%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
New Positives Dx in
2013
In HIV care Retained in HIV care Viral suppression
(<=200)
Percentage
198
118
150
111
74% of persons in care were virally suppressed
Louisiana STD/HIV Program
Evaluating Linkage to Care
• How do you evaluate linkage/retention in
care at your agency?
• Do you collect any data to look at linkage to
care?
• What are the data gaps?
• How can SHP help provide you useful data?
Questions?
For more information:
Debbie Wendell, PhD, MPH
STD/HIV Program
Louisiana Office of Public Health
(504) 568-7474
debbie.wendell@la.gov

More Related Content

PPTX
Update on PDPH Strategic Plan – Sexual Health
PPTX
Where are we on HIV testing services - the achievements and the gaps
PDF
The Kenya HIV Testing Services Guidelines 2015
PPTX
HIV self-testing and linkage in Africa
PDF
Zimbabwe HIV Self-testing presentation
PPTX
HIVST and PrEP community consultation
PPTX
Philadelphia Department of Public Health HIV Prevention Activities
PPTX
HIV self-testing among transgender women in San Francisco - a pilot
Update on PDPH Strategic Plan – Sexual Health
Where are we on HIV testing services - the achievements and the gaps
The Kenya HIV Testing Services Guidelines 2015
HIV self-testing and linkage in Africa
Zimbabwe HIV Self-testing presentation
HIVST and PrEP community consultation
Philadelphia Department of Public Health HIV Prevention Activities
HIV self-testing among transgender women in San Francisco - a pilot

What's hot (19)

PPTX
HIV self-testing in MSM
PPTX
Epidemiology Update: Disparities in the HIV Continuum of Care
PDF
Getting to Zero San Francisco
PDF
Optimal HIV testing strategies to achieve high levels of HIV diagnosis in Sou...
PDF
Iowa TelePrEP: Delivering PrEP through Telemedicine and Public Health Partner...
 
PPT
Index Testing & Key Populations in Ghana
PPTX
Thailand experiences on PrEP and HIV self-testing
PPTX
Overview of HIV self-testing
PPTX
HIV Index Testing: The USAID DISCOVER-Health Project Experience in Zambia
PDF
Realizing the potential for HIV self-testing - a summary of latest evidence
PPTX
Annual Epidemiological Presentation, 2017 - Kathleen Brady, PDPH
PDF
Sex, Drugs & Scotland's Health- Healthcare use among people living with HIV i...
PPT
NSW STIGMA Syphilis Campaign
PPTX
Positive Persons' Forum 2016
PDF
A Decade of Behavioral HIV Prevention and Care Engagement Research in Uganda:...
PDF
Testing for Acute HIV and Early Initiation of ART
PPTX
Lessons learned from Zimbabwe on HIV self-testing and pre-exposure prophylaxis
PPTX
PrEP: the road thus far
HIV self-testing in MSM
Epidemiology Update: Disparities in the HIV Continuum of Care
Getting to Zero San Francisco
Optimal HIV testing strategies to achieve high levels of HIV diagnosis in Sou...
Iowa TelePrEP: Delivering PrEP through Telemedicine and Public Health Partner...
 
Index Testing & Key Populations in Ghana
Thailand experiences on PrEP and HIV self-testing
Overview of HIV self-testing
HIV Index Testing: The USAID DISCOVER-Health Project Experience in Zambia
Realizing the potential for HIV self-testing - a summary of latest evidence
Annual Epidemiological Presentation, 2017 - Kathleen Brady, PDPH
Sex, Drugs & Scotland's Health- Healthcare use among people living with HIV i...
NSW STIGMA Syphilis Campaign
Positive Persons' Forum 2016
A Decade of Behavioral HIV Prevention and Care Engagement Research in Uganda:...
Testing for Acute HIV and Early Initiation of ART
Lessons learned from Zimbabwe on HIV self-testing and pre-exposure prophylaxis
PrEP: the road thus far
Ad

Similar to Using Data to Improve LTC - Debbie Wendell (20)

PPT
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
PDF
Hepatitis C elimination in HIV-infected men who have sex with men: reality an...
PDF
Prevention in Her Hands: Findings from a PrEP Demonstration Study of Cisgende...
PPT
DGH Lecture Series: Michael Chung
PPTX
Integrating HIV Prevention into Primary Care
PDF
Public Health HIV/STD Control in the US in the Era of TASP: 90-90-90 and Beyond
PPTX
Health System Navigators Presentation
PPTX
Health System Navigators Presentation
PDF
Uganda JSI/STAR-EC Project end-of-project conference presentation
PDF
Uganda JSI/STAR-EC end-of-project conference presentation
PPTX
2014 Epidemiological Update by Dr. Kathleen Brady
PPTX
Making Chlamydia Screening a Priority in Medical Groups: Lessons Learned from...
PPTX
Test and Treat: The Gardner Cascade in Context
PPT
WGHA Discovery Series: Cathering Wilfert
PPTX
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
PPT
Presentation: Results of National Adherence PHE
PDF
Global Medical Cures™ | HIV TESTING IN USA
PPTX
Module 1 Background_ Sep 2021.pptx presid
PPT
Routine HIV Testing in the Community Health Center
PDF
San Diego Primary Care Providers' Attitudes to HIV and HIV Testing
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Hepatitis C elimination in HIV-infected men who have sex with men: reality an...
Prevention in Her Hands: Findings from a PrEP Demonstration Study of Cisgende...
DGH Lecture Series: Michael Chung
Integrating HIV Prevention into Primary Care
Public Health HIV/STD Control in the US in the Era of TASP: 90-90-90 and Beyond
Health System Navigators Presentation
Health System Navigators Presentation
Uganda JSI/STAR-EC Project end-of-project conference presentation
Uganda JSI/STAR-EC end-of-project conference presentation
2014 Epidemiological Update by Dr. Kathleen Brady
Making Chlamydia Screening a Priority in Medical Groups: Lessons Learned from...
Test and Treat: The Gardner Cascade in Context
WGHA Discovery Series: Cathering Wilfert
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Presentation: Results of National Adherence PHE
Global Medical Cures™ | HIV TESTING IN USA
Module 1 Background_ Sep 2021.pptx presid
Routine HIV Testing in the Community Health Center
San Diego Primary Care Providers' Attitudes to HIV and HIV Testing
Ad

More from Louisiana STD/HIV Program (LAOPH/SHP) (7)

PPTX
Racial and LGBT Health Inequities
PPTX
LA Wellness Center Project - Chris Daunis
PPTX
HIV/STD EPD Overview - Jessica Fridge
PPTX
LTC with PLWH - Jackie Bickham
PPTX
LTC Strategies for CBO's - Lara Jackson
PPTX
Social Marketing Strategies for Youth - Randi Sylve
PPTX
Social Marketing for CBO's - Randi Sylve
Racial and LGBT Health Inequities
LA Wellness Center Project - Chris Daunis
HIV/STD EPD Overview - Jessica Fridge
LTC with PLWH - Jackie Bickham
LTC Strategies for CBO's - Lara Jackson
Social Marketing Strategies for Youth - Randi Sylve
Social Marketing for CBO's - Randi Sylve

Recently uploaded (20)

PDF
OSCE Series ( Questions & Answers ) - Set 6.pdf
PDF
The_EHRA_Book_of_Interventional Electrophysiology.pdf
PPTX
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study
PDF
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
PDF
AGE(Acute Gastroenteritis)pdf. Specific.
PPTX
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
DOCX
PEADIATRICS NOTES.docx lecture notes for medical students
PPTX
Approach to chest pain, SOB, palpitation and prolonged fever
PPT
Opthalmology presentation MRCP preparation.ppt
PPTX
Introduction to Medical Microbiology for 400L Medical Students
PPTX
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
PDF
Nursing manual for conscious sedation.pdf
PPTX
y4d nutrition and diet in pregnancy and postpartum
PPTX
ROJoson PEP Talk: What / Who is a General Surgeon in the Philippines?
PDF
OSCE Series Set 1 ( Questions & Answers ).pdf
PDF
Lecture 8- Cornea and Sclera .pdf 5tg year
PPTX
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
PPTX
Wheat allergies and Disease in gastroenterology
PPTX
ANESTHETIC CONSIDERATION IN ALCOHOLIC ASSOCIATED LIVER DISEASE.pptx
PPTX
@K. CLINICAL TRIAL(NEW DRUG DISCOVERY)- KIRTI BHALALA.pptx
OSCE Series ( Questions & Answers ) - Set 6.pdf
The_EHRA_Book_of_Interventional Electrophysiology.pdf
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
AGE(Acute Gastroenteritis)pdf. Specific.
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
PEADIATRICS NOTES.docx lecture notes for medical students
Approach to chest pain, SOB, palpitation and prolonged fever
Opthalmology presentation MRCP preparation.ppt
Introduction to Medical Microbiology for 400L Medical Students
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
Nursing manual for conscious sedation.pdf
y4d nutrition and diet in pregnancy and postpartum
ROJoson PEP Talk: What / Who is a General Surgeon in the Philippines?
OSCE Series Set 1 ( Questions & Answers ).pdf
Lecture 8- Cornea and Sclera .pdf 5tg year
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
Wheat allergies and Disease in gastroenterology
ANESTHETIC CONSIDERATION IN ALCOHOLIC ASSOCIATED LIVER DISEASE.pptx
@K. CLINICAL TRIAL(NEW DRUG DISCOVERY)- KIRTI BHALALA.pptx

Using Data to Improve LTC - Debbie Wendell

  • 1. Using Data to Improve Linkage to Care Debbie Wendell, PhD, MPH Louisiana STD/HIV Program Louisiana STD/HIV Program
  • 2. How can data be used to improve programs? • Where are the biggest gaps in the HIV continuum of care? • Are there race, gender or age disparities? • How quickly are clients getting linked to care? • Are clients retained in care? • How does my agency compare to others?
  • 3. How do we measure linkage, retention and viral suppression? • Use CD4/VL results as a proxy for an HIV-related medical visit o All HIV-related test results are reportable in Louisiana o Most are reported electronically on a daily basis • Measurement standards o Linkage: Was a person newly-diagnosed with HIV linked to HIV-related medical care within 90 days? o Retention: Did a person living with HIV have 2 or more care visits within a 12 month period? o Viral Suppression: Was the most recent VL <=200?
  • 4. HIV Continuum of Care Louisiana, 2013 100% 69% 54% 49% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Persons living with HIV In HIV care Retained in HIV care Viral suppression (<=200) Percentage 18,199 9,774 12,536 8,831 70% of PLWH in care were virally suppressed Louisiana STD/HIV Program
  • 5. Percent Retained in Care among PLWH by Region, Louisiana, 2013 Louisiana STD/HIV Program 52% 60% 60% 54% 46% 51% 46% 51% 53% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Percentage Region Louisiana STD/HIV Program
  • 6. Percent Virally Suppressed among PLWH in Care by Region, Louisiana, 2013 Louisiana STD/HIV Program 68% 71% 75% 75% 71% 71% 68% 72% 76% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Percentage Region Louisiana STD/HIV Program
  • 7. HIV Continuum of Care by Race/Ethnicity Louisiana, 2013 100% 100% 100% 70% 45% 70% 54% 35% 55% 46% 35% 58% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Black Hispanic White Percentage PLWH In HIV care Retained in care Viral suppression 66% of PLWH in care were virally suppressed 77% of PLWH in care were virally suppressed 82% of PLWH in care were virally suppressed N = 12,442 N = 693 N = 4,861 Louisiana STD/HIV Program
  • 8. HIV Testing by Site Type Louisiana, 2013 Total Number of Tests (% of Tests) Number of Positive Results % Positivity Total Positives Number of New Positives % Positivity New Positives Total 95,656 1,069 1.1% 532 0.6% Parish health unit 36,347 (38%) 226 0.6% 146 0.4% Emergency department 19,484 (20%) 235 1.2% 130 0.7% Correctional facility 16,385 (17%) 275 1.7% 27 0.2% Community-based org 15,701 (16%) 279 1.8% 198 1.3% Community health clinic 4,206 (4%) 45 1.1% 25 0.6% Substance abuse clinic 2,805(3%) 5 0.2% 2 0.7% School/college 728 (1%) 4 0.5% 4 0.5%
  • 9. Linkage to Care within 90 Days Louisiana, 2007 -2014 67% 70% 70% 73% 74% 78% 79% 83% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2007 2008 2009 2010 2011 2012 2013 2014 Year of Diagnosis National HIV/AIDS Strategy Objective: 85% Louisiana STD/HIV Program
  • 10. Linkage to Care within 90 Days by Region, 2013 Louisiana STD/HIV Program 78% 74% 86% 78% 90% 87% 74% 83% 85% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Percentage Region National HIV/AIDS Strategy Objective: 85% Louisiana STD/HIV Program
  • 11. Linkage to Care – New Positives By Site Type, Louisiana, 2013 Number of New Positive Results Number Linked to Care within 90 Days % Linked to Care within 90 Days Total 532 365 69% Community-based org 198 138 70% Parish health unit 146 85 58% Emergency department 130 111 85% Correctional facility 27 12 44% Community health clinic 25 17 69% Substance abuse clinic 2 0 0% School/college 4 2 50%
  • 12. Time to Linkage to Care New Positives - CBOs, Louisiana, 2013 0 10 20 30 40 50 0-7 8-15 16-30 31-45 46-90 91-180 181-270 >270 Days to Entry into Care Louisiana STD/HIV Program
  • 13. Linkage to Care within 90 Days New Positives - CBOs, Louisiana, 2013 79% 100% 54% 81% 80% 57% 84% 70% 60% 100% 100% 0% 20% 40% 60% 80% 100% A B C D E F G H I J K CBO Louisiana STD/HIV Program National HIV/AIDS Strategy Objective: 85%
  • 14. Linkage to Care – New Positives By Gender and Race/Ethnicity, CBOs, 2013 Number of New Positive Results Number Linked to Care within 90 Days % Linked to Care within 90 Days Total 198 138 70% Female 30 16 53% Male 168 122 73% African American/Black 118 73 62% Hispanic/Latino 6 6 100% White 68 55 81%
  • 15. Linkage to Care – New Positives By Age Group, CBOs, 2013 Number of New Positive Results Number Linked to Care within 90 Days % Linked to Care within 90 Days Total 198 138 70% 16-24 years old 65 48 74% 25-44 years old 99 68 69% >=45 years old 33 21 64%
  • 16. Initial CD4 and Viral Load CBOs, 2013 • CD4 count o Range: 6 - 1,169 o Median: 448 o Average: 439 o 28 clients had a CD4 count <=200 (meet AIDS case definition) • Viral load o Range: <20 – 5,589,140 o Median: 37,080 o Average: 164,125 o 8 clients had a VL<=200 (i.e., virally suppressed)
  • 17. HIV Continuum of Care - 2014 CBO – New Positives Diagnosed in 2013 100% 76% 60% 56% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% New Positives Dx in 2013 In HIV care Retained in HIV care Viral suppression (<=200) Percentage 198 118 150 111 74% of persons in care were virally suppressed Louisiana STD/HIV Program
  • 18. Evaluating Linkage to Care • How do you evaluate linkage/retention in care at your agency? • Do you collect any data to look at linkage to care? • What are the data gaps? • How can SHP help provide you useful data?
  • 19. Questions? For more information: Debbie Wendell, PhD, MPH STD/HIV Program Louisiana Office of Public Health (504) 568-7474 debbie.wendell@la.gov